Long-term use of quetiapine in elderly patients with psychotic disorders
Tóm tắt
Từ khóa
Tài liệu tham khảo
US Bureau of Census, 1999
Malmgren, 1994, Epidemiology of aging, 16
Gregory, 1994, Pharmacological management of schizophrenia in older patients, Drugs Aging, 5, 254, 10.2165/00002512-199405040-00003
Scharf, 1993, Prescribing for the elderly: Relevance of pharmacokinetics and pharmacodynamics, Med J Aust, 158, 395, 10.5694/j.1326-5377.1993.tb121834.x
Myers, 1984, Six-month prevalence of psychiatric disorders in three communities 1980 to 1982, Arch Gen Psychiatry, 41, 959, 10.1001/archpsyc.1984.01790210041006
Grossberg, 1998, Epidemiology of psychotherapeutic drug use in older adults, Clin Geriatr Med, 14, 1, 10.1016/S0749-0690(18)30126-5
Katz, 1999, Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial, J Clin Psychiatry, 60, 107, 10.4088/JCP.v60n0207
Frenchman, 1997, Clinical experience with risperidone, haloperidol, and thioridazine for dementia-associated behavioral disturbances, Int Psychogeriatr, 9, 431, 10.1017/S1041610297004560
Devanand, 1998, A randomized, placebo-controlled dosecomparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease, Am J Psychiatry, 155, 1512, 10.1176/ajp.155.11.1512
Lieberman, 1992, Clinical profile of clozapine: Adverse reactions and agranulocytosis, Psychiatr Q, 63, 51, 10.1007/BF01064682
Alvir, 1993, Clozapine-induced agranulocytosis: Incidence and risk factors in the United States, N Engl J Med, 329, 162, 10.1056/NEJM199307153290303
Schuster, 1977, Reversal by physostigmine of clozapineinduced delirium, Clin Toxicol, 10, 437, 10.3109/15563657709046281
Wolters, 1996, Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease, Neurology, 47, 1085, 10.1212/WNL.47.4.1085
Stover, 1999, Olanzapine treatment of Parkinson's patients with psychosis, Neurology, 52, A215
Goetz, 2000, Olanzapine aggravates parkinsonism: Randomized double-blind study in hallucinating Parkinson's disease patients, Neurology, 54, A471
Graham, 1998, Olanzapine in the treatment of hallucinosis in idiopathic Parkinson's disease: A cautionary note, J Neurol Neurosurg Psychiatry, 65, 774, 10.1136/jnnp.65.5.774
Satterlee, 1995, A clinical update on olanzapine treatment in schizophrenia and in elderly Alzheimer's disease patients, Psychopharmacol Bull, 31, 534
Street, 1999, Olanzapine reduces psychosis and behavioral disturbances associated with Alzheimer's disease, Int Psychogeriatr, 11, 139
Goldstein, 1995, ICI 204636 (SEROQUEL™): A dibenzothiazepine atypical antipsychotic. Review of preclinical pharmacology and highlights of Phase II clinical trials, CNS Drug Rev, 1, 50, 10.1111/j.1527-3458.1995.tb00276.x
Goldstein, 1995, Pre-clinical pharmacology of new atypical antipsychotics in late stage development, Expert Opin Invest Drugs, 4, 291, 10.1517/13543784.4.4.291
Arvanitis, 1997, Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo, Biol Psychiatry, 42, 233, 10.1016/S0006-3223(97)00190-X
Small, 1997, Quetiapine in patients with schizophrenia. A high-and low-dose double-blind comparison with placebo, Arch Gen Psychiatry, 54, 549, 10.1001/archpsyc.1997.01830180067009
Borison, 1996, ICI 204,636, an atypical antipsychotic: Efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia, J Clin Psychopharmacol, 16, 158, 10.1097/00004714-199604000-00008
Peuskens, 1997, A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia, Acta Psychiatr Scand, 96, 265, 10.1111/j.1600-0447.1997.tb10162.x
Wong, 1997, Multi-dose-dose pharmacokinetics of “Seroquel” (quetiapine) in elderly psychotic patients, Schizophr Res, 24, 200
McManus, 1999, Quetiapine, a novel antipsychotic: Experience in elderly patients with psychotic disorders, J Clin Psychiatry, 60, 292, 10.4088/JCP.v60n0504
American Psychiatric Association, 1994
Simpson, 1970, A rating scale for extrapyramidal side effects, Acta Psychiatr Scand, 212, 11, 10.1111/j.1600-0447.1970.tb02066.x
AIMS, 1976, ECDEU Assessment Manual for Psychopharmacology, 534
CGI Clinical Global Impressions, 1976, ECDEU Assessment Manual for Psychopharmacology, 218
1995
Nolan, 1998, Absence of vascular dementia in an autopsy series from a dementia clinic, J Am Geriatr Soc, 46, 597, 10.1111/j.1532-5415.1998.tb01076.x
Blumenthal, 1980, Dizziness and falling in elderly psychiatric outpatients, Am J Psychiatry, 137, 203, 10.1176/ajp.137.2.203
Loy, 1999, Alzheimer's disease: Behavioral management, 136